Description
This presentation will nclude a brief intro about company profile an financial analysis & will include different ratio's with graphical representation its interpretations and conclusions
Contents
• Company profile • Awards and Achievements • Financial Analysis
? Balance Sheet ? Profit/Loss A/c
• Ratio Analysis
Company Profile
• Biocon Limited is an Indian biopharmaceutical company based in Bangalore. • Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. • Biocon has two subsidiaries— Syngene , a custom research organisation, and Clinigene, a clinical research organisation. • Biocon’s presence straddles four main therapeutic areas— Diabetology, Cardiology, Nephrology and Oncology.
Awards and Achievement
• 2010: Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore.
•
2009: – Among Top 20 Indian companies in Forbes ‘Best Under A Billion’ list – Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore
2008: – Ranked among the top 20 global biotechnology companies (Source: Med Ad News, June 2008) – 7th largest biotech employer in the world (Source: Med Ad News, June 2008) 2006: Best IT User Award in the Pharmaceutical Sector, NASSCOM 2004: – India's first and No. 1 biotech company with a global ranking of 16 . – India's top 5 Life Sciences companies (at close of trade as on 30 July 2004) – Best Employer of India Award, Hewitt.
•
• •
Financial Analysis
Balance sheet a/c
Mar '13 12 mths Sources Of Funds Total Share Capital Equity Share Capital Share Application Money Preference Share Capital Init. Contribution Settler Preference Share Application Money Employee Stock Opiton Reserves Revaluation Reserves Networth Secured Loans Unsecured Loans Total Debt Minority Interest Policy Holders Funds Group Share in Joint Venture Total Liabilities 100.00 100.00 0.00 0.00 0.00 0.00 0.00 2,594.60 0.00 2,694.60 154.20 94.60 248.80 65.30 0.00 0.00 3,008.70 100.00 100.00 0.00 0.00 0.00 0.00 0.00 2,172.40 0.00 2,272.40 90.40 166.70 257.10 3.80 0.00 0.00 2,533.30 Mar '12 12 mths
Application Of Funds Gross Block Less: Accum. Depreciation Net Block 2,584.60 967.20 1,617.40 2,158.90 785.20 1,373.70
Capital Work in Progress
Investments Inventories Sundry Debtors Cash and Bank Balance Total Current Assets Loans and Advances Fixed Deposits Total CA, Loans & Advances
205.40
586.60 398.40 509.70 672.90 1,581.00 425.70 0.00 2,006.70
286.30
556.30 378.30 491.70 523.30 1,393.30 335.40 0.00 1,728.70
Deffered Credit
Current Liabilities Provisions Total CL & Provisions Net Current Assets Minority Interest Group Share in Joint Venture Miscellaneous Expenses Total Assets Contingent Liabilities
0.00
1,156.90 250.50 1,407.40 599.30 0.00 0.00 0.00 3,008.70 898.90
0.00
1,200.20 211.50 1,411.70 317.00 0.00 0.00 0.00 2,533.30 406.30
Profit /Loss Statement
Mar '13 Mar '12 12 mths 12 mths
Income Sales Turnover Excise Duty Net Sales Other Income 2,530.60 45.30 2,485.30 254.60 2,136.00 50.00 2,086.00 64.50
Stock Adjustments
Total Income Expenditure Raw Materials
26.50
2,766.40
44.50
2,195.00
1,111.20
933.80
Power & Fuel Cost
Employee Cost Other Manufacturing Expenses Selling and Admin Expenses Miscellaneous Expenses Preoperative Exp Capitalised Total Expenses
142.60
389.40 23.70 0.00 301.90 0.00 1,968.80
97.20
307.60 22.40 0.00 252.20 0.00 1,613.20
Operating Profit PBDIT Interest PBDT Depreciation Other Written Off Profit Before Tax Extra-ordinary items PBT (Post Extra-ord Items) Tax Reported Net Profit Minority Interest Share Of P/L Of Associates Net P/L After Minority Interest & Share Of Associates Total Value Addition Preference Dividend Equity Dividend Corporate Dividend Tax Per share data (annualised) Shares in issue (lakhs) Earning Per Share (Rs) Equity Dividend (%) Book Value (Rs)
543.00 797.60 8.10 789.50 179.30 0.00 610.20 0.00 610.20 97.50 512.70 3.80 0.00 307.00 857.60 0.00 150.00 25.50 2,000.00 25.64 0.00 134.73
517.30 581.80 12.20 569.60 174.40 0.00 395.20 0.00 395.20 55.90 339.30 0.90 0.00 335.70 679.40 0.00 100.00 16.20 2,000.00 16.97 0.00 113.62
Ratio Analysis
Current Ratio
1.45 1.4 1.35 1.3
Current ratio = current asset/current liabilities
Current ratio(2012) =1728.7/1411.7 =1.22
1.25
1.2 1.15 1.1
Current ratio(2013) =2006.7/1407.4 =1.43
2012 2013
Quick/Liquid ratio
1.15
• Quick ratio =liquid assets/current
1.1
liabilities
• Quick ratio(2012) = 1350.4/1411.7
1.05
1
= 0.95 • Quick ratio(2013) =1608.3\1407.4 = 1.14
0.95
0.9
0.85 2012 2013
Debt-Equity Ratio
0.12 0.1 0.08
• Debt equity ratio=
long term debts/equity or
share holder funds • Debt equity ratio(2012)
0.06 0.04
=257.1/2272.4 =0.11 • Debt equity ratio (2013) =248.8/2694.6 =0.09
0.02
0 2012 2013
Proprietary Ratio
0.9
0.8
0.7 0.6 0.5 0.4 0.3 0.2
• Formula = Equity / total assets • For 2012 =2272.4/2533.3 =0.89 • For 2013 =2694.6/3008.7 =0.89
0.1
0 2012 2012
Capital Gearing Ratio
0.12 0.1 0.08
• Formula =Equity share capital + reserves + P&L Balance /Fixed cost bearing capital. • For 2012 =257.1/2272.4 =0.11 • For 2013 =248.8/2694.6 =0.09
0.06
0.04 0.02 0 2012 2013
Total asset to Debt ratio
14 12 10
• Formula =Total asset / Long term debt
8
6 4 2 0 2012 2013
• Total asset to debt ratio (2012) =2533.3/257.1 =9.85
• Total asset to debt ratio(2013) = 3008.7/248.8 = 12.09
Fixed Asset turnover Ratio
1 0.9 0.8
• Formula – Cost of goods sold/Net fixed assets. • For 2013 = 2485.3/2584.6 =0.96 • For 2012 =2086/2158.9 =0.96
2012 2013
0.7
0.6 0.5 0.4 0.3 0.2
0.1
0
Net Profit Ratio
20 18 16 14 12
• Net profit ratio= net profit*100/net sales
• Net profit ratio(2013) = 512.7*100/2485.3 = 20 • Net profit ratio(2012) =339.3*100/2086
10
8 6 4 2 0 2012 2013
=16
Interest coverage ratio
80 70
60
50 40 30 20
• Formula= Net profit before charging interest and tax /Fixed interest charges. • For 2012 =395.2/12.2 =32.39 • For 2013 =610.2/8.1 =75.33
2012 2013
10
0
Return on capital employed
25 • Rate on capital = Profit before Tax * 100 /Employed Capital employed. Return on Capital employed =407.4*100 /2529.5 =16 Return on capital employed (2013) =618.3*100 / 2943.4 =21
20 • 15 •
10
5
0 2012 2013
Working capital turnover Ratio
7 6 5 4 3 2
• Working capital turnover ratio= sales/ working capital • Working capital turnover Ratio (2012) =2086/317 = 6.58 • Working capital turnover ratio (2013) =2485.3/ 5995.3 = 4.14
1
0
2012
2013
Conclusions
In balance sheet:• • • • • Net worth has increase substantially Total debt decreases following year. Total liabilities increase with relation to 2012. Current liabilities decreases. Current assets and Total assets both increases .
In Profit/Loss a/c:• • • • Total Income increases. Total expenses increases. Net profit increases. Net sales increases.
doc_554388434.pptx
This presentation will nclude a brief intro about company profile an financial analysis & will include different ratio's with graphical representation its interpretations and conclusions
Contents
• Company profile • Awards and Achievements • Financial Analysis
? Balance Sheet ? Profit/Loss A/c
• Ratio Analysis
Company Profile
• Biocon Limited is an Indian biopharmaceutical company based in Bangalore. • Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. • Biocon has two subsidiaries— Syngene , a custom research organisation, and Clinigene, a clinical research organisation. • Biocon’s presence straddles four main therapeutic areas— Diabetology, Cardiology, Nephrology and Oncology.
Awards and Achievement
• 2010: Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore.
•
2009: – Among Top 20 Indian companies in Forbes ‘Best Under A Billion’ list – Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore
2008: – Ranked among the top 20 global biotechnology companies (Source: Med Ad News, June 2008) – 7th largest biotech employer in the world (Source: Med Ad News, June 2008) 2006: Best IT User Award in the Pharmaceutical Sector, NASSCOM 2004: – India's first and No. 1 biotech company with a global ranking of 16 . – India's top 5 Life Sciences companies (at close of trade as on 30 July 2004) – Best Employer of India Award, Hewitt.
•
• •
Financial Analysis
Balance sheet a/c
Mar '13 12 mths Sources Of Funds Total Share Capital Equity Share Capital Share Application Money Preference Share Capital Init. Contribution Settler Preference Share Application Money Employee Stock Opiton Reserves Revaluation Reserves Networth Secured Loans Unsecured Loans Total Debt Minority Interest Policy Holders Funds Group Share in Joint Venture Total Liabilities 100.00 100.00 0.00 0.00 0.00 0.00 0.00 2,594.60 0.00 2,694.60 154.20 94.60 248.80 65.30 0.00 0.00 3,008.70 100.00 100.00 0.00 0.00 0.00 0.00 0.00 2,172.40 0.00 2,272.40 90.40 166.70 257.10 3.80 0.00 0.00 2,533.30 Mar '12 12 mths
Application Of Funds Gross Block Less: Accum. Depreciation Net Block 2,584.60 967.20 1,617.40 2,158.90 785.20 1,373.70
Capital Work in Progress
Investments Inventories Sundry Debtors Cash and Bank Balance Total Current Assets Loans and Advances Fixed Deposits Total CA, Loans & Advances
205.40
586.60 398.40 509.70 672.90 1,581.00 425.70 0.00 2,006.70
286.30
556.30 378.30 491.70 523.30 1,393.30 335.40 0.00 1,728.70
Deffered Credit
Current Liabilities Provisions Total CL & Provisions Net Current Assets Minority Interest Group Share in Joint Venture Miscellaneous Expenses Total Assets Contingent Liabilities
0.00
1,156.90 250.50 1,407.40 599.30 0.00 0.00 0.00 3,008.70 898.90
0.00
1,200.20 211.50 1,411.70 317.00 0.00 0.00 0.00 2,533.30 406.30
Profit /Loss Statement
Mar '13 Mar '12 12 mths 12 mths
Income Sales Turnover Excise Duty Net Sales Other Income 2,530.60 45.30 2,485.30 254.60 2,136.00 50.00 2,086.00 64.50
Stock Adjustments
Total Income Expenditure Raw Materials
26.50
2,766.40
44.50
2,195.00
1,111.20
933.80
Power & Fuel Cost
Employee Cost Other Manufacturing Expenses Selling and Admin Expenses Miscellaneous Expenses Preoperative Exp Capitalised Total Expenses
142.60
389.40 23.70 0.00 301.90 0.00 1,968.80
97.20
307.60 22.40 0.00 252.20 0.00 1,613.20
Operating Profit PBDIT Interest PBDT Depreciation Other Written Off Profit Before Tax Extra-ordinary items PBT (Post Extra-ord Items) Tax Reported Net Profit Minority Interest Share Of P/L Of Associates Net P/L After Minority Interest & Share Of Associates Total Value Addition Preference Dividend Equity Dividend Corporate Dividend Tax Per share data (annualised) Shares in issue (lakhs) Earning Per Share (Rs) Equity Dividend (%) Book Value (Rs)
543.00 797.60 8.10 789.50 179.30 0.00 610.20 0.00 610.20 97.50 512.70 3.80 0.00 307.00 857.60 0.00 150.00 25.50 2,000.00 25.64 0.00 134.73
517.30 581.80 12.20 569.60 174.40 0.00 395.20 0.00 395.20 55.90 339.30 0.90 0.00 335.70 679.40 0.00 100.00 16.20 2,000.00 16.97 0.00 113.62
Ratio Analysis
Current Ratio
1.45 1.4 1.35 1.3
Current ratio = current asset/current liabilities
Current ratio(2012) =1728.7/1411.7 =1.22
1.25
1.2 1.15 1.1
Current ratio(2013) =2006.7/1407.4 =1.43
2012 2013
Quick/Liquid ratio
1.15
• Quick ratio =liquid assets/current
1.1
liabilities
• Quick ratio(2012) = 1350.4/1411.7
1.05
1
= 0.95 • Quick ratio(2013) =1608.3\1407.4 = 1.14
0.95
0.9
0.85 2012 2013
Debt-Equity Ratio
0.12 0.1 0.08
• Debt equity ratio=
long term debts/equity or
share holder funds • Debt equity ratio(2012)
0.06 0.04
=257.1/2272.4 =0.11 • Debt equity ratio (2013) =248.8/2694.6 =0.09
0.02
0 2012 2013
Proprietary Ratio
0.9
0.8
0.7 0.6 0.5 0.4 0.3 0.2
• Formula = Equity / total assets • For 2012 =2272.4/2533.3 =0.89 • For 2013 =2694.6/3008.7 =0.89
0.1
0 2012 2012
Capital Gearing Ratio
0.12 0.1 0.08
• Formula =Equity share capital + reserves + P&L Balance /Fixed cost bearing capital. • For 2012 =257.1/2272.4 =0.11 • For 2013 =248.8/2694.6 =0.09
0.06
0.04 0.02 0 2012 2013
Total asset to Debt ratio
14 12 10
• Formula =Total asset / Long term debt
8
6 4 2 0 2012 2013
• Total asset to debt ratio (2012) =2533.3/257.1 =9.85
• Total asset to debt ratio(2013) = 3008.7/248.8 = 12.09
Fixed Asset turnover Ratio
1 0.9 0.8
• Formula – Cost of goods sold/Net fixed assets. • For 2013 = 2485.3/2584.6 =0.96 • For 2012 =2086/2158.9 =0.96
2012 2013
0.7
0.6 0.5 0.4 0.3 0.2
0.1
0
Net Profit Ratio
20 18 16 14 12
• Net profit ratio= net profit*100/net sales
• Net profit ratio(2013) = 512.7*100/2485.3 = 20 • Net profit ratio(2012) =339.3*100/2086
10
8 6 4 2 0 2012 2013
=16
Interest coverage ratio
80 70
60
50 40 30 20
• Formula= Net profit before charging interest and tax /Fixed interest charges. • For 2012 =395.2/12.2 =32.39 • For 2013 =610.2/8.1 =75.33
2012 2013
10
0
Return on capital employed
25 • Rate on capital = Profit before Tax * 100 /Employed Capital employed. Return on Capital employed =407.4*100 /2529.5 =16 Return on capital employed (2013) =618.3*100 / 2943.4 =21
20 • 15 •
10
5
0 2012 2013
Working capital turnover Ratio
7 6 5 4 3 2
• Working capital turnover ratio= sales/ working capital • Working capital turnover Ratio (2012) =2086/317 = 6.58 • Working capital turnover ratio (2013) =2485.3/ 5995.3 = 4.14
1
0
2012
2013
Conclusions
In balance sheet:• • • • • Net worth has increase substantially Total debt decreases following year. Total liabilities increase with relation to 2012. Current liabilities decreases. Current assets and Total assets both increases .
In Profit/Loss a/c:• • • • Total Income increases. Total expenses increases. Net profit increases. Net sales increases.
doc_554388434.pptx